Stocks · News reference

BTIG Maintains Buy on BrainsWay, Raises Price Target to $20

Aug 12, 2026, 5:09 PMBenzinga Newsdesk

BTIG analyst Sam Eiber maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $18 to $20.

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Aug 12, 2026, 5:09 PM
Checked: Aug 12, 2026, 5:09 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 27, 2026, 11:30 AMBenzinga Newsdesk
BrainsWay Says Secondary Analysis Of Deep TMS Trial Published In Journal Of Affective Disorders Showed Suicidal Ideation Fell From 22.5% Of 89 Patients At Baseline To 6.7% At Six Weeks
Read original at benzinga
BWAY
BenzingaAug 13, 2026, 6:32 PMBenzinga Newsdesk
Ladenburg Thalmann Maintains Buy on BrainsWay, Raises Price Target to $18.8
Ladenburg Thalmann analyst Jeffrey Cohen maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $18 to $18.8.
Read original at benzinga
BWAY
BenzingaAug 12, 2026, 6:51 PMBenzinga Newsdesk
BrainsWay shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY26 sales guidance above analyst estimates.
Read original at benzinga
BWAY